Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-031923

Chief Financial Officer bought 58,486 shares at an average $1.56 ($91,082)

From the SEC's structured data for this filing

Trades in this filing

Byam Rebecca · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-22 Purchase : show line 1 in the form +33,450 $1.53 $51,045 395,152 D
2023-05-23 Purchase : show line 2 in the form +5,036 $1.57 $7,887 400,188 D
2023-05-24 Purchase : show line 3 in the form +20,000 $1.61 $32,150 420,188 D
Open-market purchases · 58,486 sh · avg $1.56 · $91,082
Loading xslF345X04/doc4.xml…